Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015

Stavudine (D4T), zidovudine (AZT), and tenofovir (TDF) along with lamivudine (3TC) are the most widely used HIV treatment regimens in China. China's National Free Antiretroviral Treatment Programme (NFATP) has replaced D4T with AZT or TDF in the standard first-line regimens since 2010. Few stud...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Medicine (Baltimore)
Главные авторы: Liu, Pengtao, Liao, Lingjie, Xu, Wei, Yan, Jing, Zuo, Zhongbao, Leng, Xuebing, Wang, Jing, Kan, Wei, You, Yinghui, Xing, Hui, Ruan, Yuhua, Shao, Yiming
Формат: Artigo
Язык:Inglês
Опубликовано: Wolters Kluwer Health 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6320000/
https://ncbi.nlm.nih.gov/pubmed/30558015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013555
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы